An Observational Cohort Study of Targeted Antibiotic Treatments of Cystic Fibrosis Exacerbations
MIC-guided antibiotic dosing prolongs time between pulmonary exacerbations with few adverse events. Reduced exacerbation frequency predicts better survival and may improve quality of life for people with CF.
Authors
- Theodore G. Liou (ORCID: https://orcid.org/0000-0003-0121-4847)
- Rhonda D. Szczesniak (ORCID: https://orcid.org/0000-0003-0705-715X)
- Luis G. Vargas Buonfiglio (ORCID: https://orcid.org/0000-0001-8252-0859)
- Warren E. Regelmann
- Zubin Bhakta
- Mark A. Fisher (ORCID: https://orcid.org/0000-0002-7138-7025)
- H. R. D. Jacobs
- Kristyn A. Packer
- Andrew Ulrich
- David C Young
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- University of Minnesota (US)
- University of Utah (US)
- Quantitative BioSciences (US)
- Utah Department of Health (US)
- University of Utah Health Care (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-12-06
- DOI
- https://doi.org/10.1093/ofid/ofaf745
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cystic Fibrosis Foundation